Editas Medicine, Inc. — Director's Dealing 2021

Jun 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2021-06-03

Reporting Person: Scadden David (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-03	Stock Option (right to buy)	$33.36	A	11538	Acquired	2031-06-02	Common Stock (11538)	Direct

Footnotes

F1: This option was granted on June 3, 2021 and is scheduled to vest in full on June 3, 2022.